# Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

> **NCT00951041** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 130 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK investigational vaccine GSK2340272A
- **BIOLOGICAL:** GSK investigational vaccine GSK2340269A

## Key facts

- **NCT ID:** NCT00951041
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-11
- **Primary completion:** 2010-08-30
- **Final completion:** 2010-08-30
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2018-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951041, "Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00951041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*